May 24, 2025, 05:52 | Blog

Robin Zon Shared New Podcast Episode with ASCO 2025 Meeting Scientific Program Chair Erika Hamilton

Robin Zon, President of ASCO 2024-2025, shared a post on LinkedIn: "As we gear up…

May 18, 2025, 12:41 | Blog

Erika Hamilton Offers Free Registration Code for All Healthcare Providers at 24th IBC East Conference

Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…

May 16, 2025, 11:26 | Blog

Antonio Giordano: Important question - which 1L CDK4/6i to preserve efficacy of re-cycling cell cycle in 2L?

Antonio Giordano, Breast Medical Oncologist at Dana-Farber Cancer Institute, shared a post by Erika Hamilton,…

May 13, 2025, 09:24 | Blog

Erika Hamilton and Noelle Cloven on National Women’s Health Week 2025

Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…

May 12, 2025, 09:38 | Blog

Erika Hamilton: I'm Leaving Today for ESMOBreast25

Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…

May 12, 2025, 09:13 | Blog

Zhen Su: Excited to announce our second clinical trial of the START clinical Program

Zhen Su, CEO at Marengo Therapeutics, shared a post on LinkedIn: "Building on the strong…

May 12, 2025, 04:22 | Blog

Vivek Subbiah: Big thanks to Zhen Su for sharing impressive data from START001

Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared…

May 9, 2025, 10:15 | Blog

Sarah Sammons Comments on TDXd Use in Early HER2+ Breast Cancer

Sarah Sammons, Breast Medical Oncologist at the Dana-Farber Cancer Institute, shared a post on X…

May 9, 2025, 09:37 | Blog

Erika Hamilton: PROTAC Data at ASCO25 in the MBC Oral Session

Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…

May 9, 2025, 05:39 | Drugs

Erika Hamilton: Zanidatamab Combination Shows Promising Results in HR+/HER2+ Metastatic Breast Cancer

Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…

May 5, 2025, 10:37 | Blog

Amol Akhade Launches Clinician Poll on Adjuvant Therapy for Breast Cancer

Amol Akhade, Senior Consultant Medical Oncologist and Hemato-Oncologist at Suyog Cancer Clinics and Reliance Hospitals, shared…

Apr 20, 2025, 14:07 | Blog

Erika Hamilton: ESMO Breast Cancer 2025 is next month

Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…

Apr 14, 2025, 09:50 | Blog

Mythili Shastry: Excited to cochair the symposium on "Antibody-Based Cancer Therapeutic Agents" at AACR 2025

Mythili Shastry, Associate Director at Sarah Cannon Research Institute, posted on LinkedIn: "Excited to cochair…

Apr 11, 2025, 06:17 | Blog

Erika Hamilton: Sarah Cannon Research Institute is growing this year

Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…

Apr 2, 2025, 16:22 | Blog

Erika Hamilton: So proud of the contributions from Melissa Johnson and SCRI Oncology Partners here and abroad

Erika Hamilton, Chair, Executive Committee Breast and Breast Program Lead at Sarah Cannon Research Institute,…

Mar 24, 2025, 10:29 | Blog

Erika Hamilton: Registration is open for the 24th Annual International Congress on the Future of Breast Cancer East

Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…

Mar 12, 2025, 06:49 | Blog

Erika Hamilton: Planning ASCO25 scientific program

Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…

Mar 11, 2025, 12:26 | Blog

Erika Hamilton: JSMO25 was amazing

Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…

Mar 9, 2025, 12:46 | Blog

Erika Hamilton: A fantastic meeting with our colleagues across Asia at JSMO 2025

Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…

Jan 23, 2025, 19:05 | Blog

Erika Hamilton: ASCO25 abstract deadline is 5 days away

Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…

Jan 23, 2025, 14:32 | Blog

Erika Hamilton: A true team at Sarah Cannon Research Institute

Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…

Jan 19, 2025, 07:17 | Science

Abemaciclib Plus Fulvestrant in Advanced Breast Cancer

Dana-Farber’s Breast Oncology Center posted on X, about recent paper by Kevin Kalinsky et al.,…

Jan 15, 2025, 15:57 | Positive

William Pao: Breakthrough - The Quest for Life-Changing Medicines

William Pao, Chief Executive Officer of Revelio Therapeutics, shared a post on LinkedIn: "Today is…

Jan 8, 2025, 11:37 | Blog

Aakash Desai: Sacituzumab govitecan continues to show promise as a 2-line treatment for extensive-stage SCLC

Aakash Desai, Assistant Professor at UAB O’Neal Comprehensive Cancer Center, shared on LinkedIn: "Sacituzumab govitecan…

Jan 4, 2025, 15:18 | Insight

Vivek Subbiah: Top Phase 1 clinical trial publications of 2024

Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared…

Dec 28, 2024, 15:46 | Drugs

Paolo Tarantino: Dato-DXd is now approved in Japan for HR+/HER2- MBC

Paolo Tarantino, Research fellow at Dana-Farber Cancer Institute and Harvard Medical School, shared a post…

Dec 27, 2024, 10:48 | Drugs

Raffaele Colombo: Dato-DXd approved in Japan for HR+, HER-negative unresectable or recurrent breast cancer

Raffaele Colombo, Associate Director of Medicinal Chemistry at Zymeworks, shared on X: “Datopotamab deruxtecan (dato-DXd)…

Dec 26, 2024, 15:50 | Insight

Breast Cancer Research Digest by Dana-Farber’s Breast Oncology Center

Dana-Farber’s Breast Oncology Center shared a post on X: “Here’s the most recent Breast Cancer…

Dec 24, 2024, 14:02 | Science

Stephanie Graff: Abemaciclib Plus Fulvestrant in Advanced Breast Cancer

Stephanie Graff, Director of Breast Oncology at Brown University Health, posted on X about recent…

Dec 23, 2024, 12:23 | Science

Paolo Tarantino: PostMONARCH is out in Journal of Clinical Oncology

A recent paper by Kevin Kalinsky, Director of the Glenn Family Breast Center at Winship,…

Dec 20, 2024, 02:13 | Blog

Erika Hamilton: Honored to have been elected to the ASCO Nominating Committee

Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…

Dec 19, 2024, 21:27 | Blog

Robin Zon: ASCO25 is sure to inform, inspire and innovate!

Robin Zon , President of ASCO for 2024-2025, shared a post by Erika Hamilton, Director…

Dec 19, 2024, 14:18 | Blog

ACSBCN - Learning about the latest advancements in breast cancer research in SABCS

American Cancer Society National Breast Cancer Roundtable shared on LinkedIn: "ACS NBCRT Strategic Director, Melissa…

Dec 16, 2024, 17:51 | Insight

Best of 2024 SABCS - San Antonio Breast Cancer Symposium

The SABCS 2024 (San Antonio Breast Cancer Symposium) took place from December 10th to 13th,…

Dec 16, 2024, 04:11 | Insight

Highlights from Day 4 of SABCS 2024

The SABCS 2024 (San Antonio Breast Cancer Symposium) took place from December 10th to 13th,…

Dec 15, 2024, 08:06 | Blog

Erika Hamilton: Advancing breast cancer care at SABCS

Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…

Dec 14, 2024, 13:35 | Blog

Arif Kamal: Only 7% of adults with a cancer diagnosis enroll in a therapeutic clinical trial

Arif Kamal, Chief Patient Officer for the American Cancer Society, shared a post on LinkedIn:…

Dec 14, 2024, 01:08 | Blog

Erika Hamilton: Does remote symptom monitoring improve fatigue in MBC?

Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…

Dec 13, 2024, 22:22 | Blog

SABCS24 Day 3 Highlights from Oncology Brothers

Oncology Brothers shared a post on X: "SABCS24 Day 3 Highlights 1. EUROPA: ET vs…

Dec 13, 2024, 19:52 | Blog

Insights on EMBER3 trial from SABCS 2024

Imlunestrant has been approved for the treatment of breast cancer. It is a next-generation, brain-penetrant,…

Dec 13, 2024, 18:46 | Blog

Erika Hamilton: For those healthy enough for surgery, do it in cases of breast cancer

Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…

Dec 13, 2024, 16:47 | Insight

Erika Hamilton presented results from a post-hoc exploratory analysis of the NATALEE trial at SABCS24

TRIO - Translational Research in Oncology shared a post on LinkedIn: “TRIO News from SABCS2024!…

Dec 13, 2024, 14:30 | Insight

Day 2 Highlights of SABCS24 by Erika Hamilton

The San Antonio Breast Cancer Symposium (SABCS) 2024 is taking place from December 10-13 in…

Dec 13, 2024, 05:58 | Blog

Erika Hamilton: Risk reducing surgery in young BRCA carriers with a prior Breast Cancer, by Matteo Lambertini

Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…

Dec 13, 2024, 05:49 | Insight

Highlights from Day 3 of SABCS 2024

The SABCS 2024 (San Antonio Breast Cancer Symposium) is taking place from December 10th to…

Dec 12, 2024, 14:12 | Blog

SABCS24 Day 2 Highlights from Oncology Brothers

Oncology Brothers posted on X: "SABCS24 Day 2 Highlights 1. EMBER3: Oral SERD in HR+…

Dec 12, 2024, 13:36 | Blog

Imlunestrant with or without Abemaciclib in Advanced Breast Cancer

Erika Hamilton, The Director of Breast Cancer Program at Sarah Cannon Research Institute, shared on…

Dec 11, 2024, 19:12 | Insight

Highlights from Day 1 of SABCS 2024

The SABCS 2024 (San Antonio Breast Cancer Symposium) is taking place from December 10th to…

Dec 11, 2024, 17:38 | Blog

SABCS24 Day 1 Highlights by Oncology Brothers

Oncology Brothers shared a post on X: "SABCS24 Day 1 Highlights CommunityOnc: FDA Oncology Reviews recent…

Dec 10, 2024, 16:07 | Opinion

Breast Cancer Research Digest by Dana-Farber Breast Oncology Center

Dana-Farber’s Breast Oncology Center shared on X: “Here’s the Breast Cancer Research Digest - a…

Dec 9, 2024, 16:49 | Insight

Erika Hamilton: ADCs are changing breast cancer care

Erika Hamilton, Director of Breast Cancer Program at Sarah Cannon Research Institute, shared on LinkedIn:…

Dec 3, 2024, 18:34 | Insight

Toxicity check for commonly used ADCs with Erika Hamilton and Tian Zhang

Oncology Brothers shared a post on X: “Approval is just a start, managing AEs for…

Nov 30, 2024, 22:15 | Blog

Giampaolo Bianchini: Cast your vote in the ASCO 2025 election

Giampaolo Bianchini, Head of the Translational and Immunotherapy Research Group at the San Raffaele Scientific…

Nov 28, 2024, 18:17 | Blog

SABCS's Social Media Ambassadors 2024

The SABCS 2024 (San Antonio Breast Cancer Symposium) will feature a group of Social Media…

Nov 24, 2024, 17:23 | Blog

ASCO is offering payment waivers to first authors from low-income and lower-middle-income countries

ASCO (American Society of Clinical Oncology) shared on X: "Did you hear the news? To support…

Nov 22, 2024, 16:40 | Blog

Voting in the ASCO Election is open until December 3

Erika Hamilton, Chair, Executive Committee Breast and Breast Program Lead at Sarah Cannon Research Institute,…

Nov 21, 2024, 16:00 | Blog

Mark E. Cooper will be joining SCRI to help coordinate a comprehensive breast program

Erika Hamilton, Medical Oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…

Nov 15, 2024, 16:18 | Opinion

Erika Hamilton: Harold Burstein and Thomas Grinda on anthracyline use in early breast cancer

Erika Hamilton, the Director of Breast Cancer Program at Sarah Cannon Research Institute, shared on LinkedIn: "Harold…

Nov 13, 2024, 11:34 | Blog

Erika Hamilton: Inspired by the strength of the veteran patients and their commitment to continue fighting

Erika Hamilton shared on LinkedIn: "Today, I want to take a moment to honor and thank…

Nov 12, 2024, 18:55 | Insight

María Natalia Gandur Quiroga: Just cast my vote for the ASCO election

María Natalia Gandur Quiroga, Coordinator in charge of the Urological Clinical Service of the Angel…

Nov 11, 2024, 22:32 | Blog

Vivek Subbiah: ASCO elections are open! Delighted to endorse Erika Hamilton

Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute (USA), shared…

Nov 11, 2024, 02:47 | Insight

Erika Hamilton - Candidate for ASCO Nominating Committee

Erika Hamilton has been nominated as the Undesignated Member Candidate of the nomination committee for…

Nov 10, 2024, 15:34 | Blog

Erika Hamilton: ASCO25 abstracts are open!

Erika Hamilton, the Director of Breast Cancer Program at Sarah Cannon Research Institute, shared a…

Nov 10, 2024, 13:41 | Blog

The most recent Breast Cancer Research Digest by Dana-Farber Cancer Institute

Dana-Farber’s Breast Oncology Center shared on X: "Check out the Breast Cancer Research Digest -…

Nov 7, 2024, 16:16 | Blog

Rohit Gosain: Excited to see these outstanding ASCO candidates

Rohit Gosain, Co-Host of Podcast Oncology Brothers, shared a post on LinkedIn: "It's crucial to…

Nov 5, 2024, 15:51 | Blog

Paolo Tarantino: Honored to moderate the SABCS 2024 People’s Choice session

Paolo Tarantino posted on X: "Honored to moderate the SABCS 2024 People’s Choice session on…

Nov 4, 2024, 13:32 | Insight

Paolo Tarantino: The SERENA-2 phase 2 trial of camizestrant vs fulvestrant is out

Paolo Tarantino, Research Fellow at The Dana-Farber Cancer Institute, shared on X: “The SERENA-2 phase…

Nov 4, 2024, 13:28 | Insight

Strategies to prevent and manage antibody-drug conjugate-associated nausea and vomiting

Sarah Cannon Docs shared a post on X: “SCRI breast cancer expert Erika Hamilton, joins…

Nov 2, 2024, 12:01 | Positive

Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

As Pink October has ended, it's time to reflect on Breast Cancer Awareness Month. OncoDaily…

Oct 28, 2024, 08:58 | Insight

Five articles suggested by Yüksel Ürün

Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey.…

Oct 26, 2024, 10:40 | Blog

Erika Hamilton: The latest advances and controversial topics in the field of breast and gynecological cancers

Erika Hamilton, Medical oncologist and the Director of Breast Cancer Program at Sarah Cannon Research…

Oct 23, 2024, 13:56 | Blog

Erika Hamilton: The latest breast cancer trends

Erika Hamilton shared on Linkedin: ''When it comes to breast cancer, we face both progress…

Oct 23, 2024, 13:33 | Blog

Erika Hamilton: Clinical trials should be the first option in fighting cancer not the last

Erika Hamilton shared a post by Sarah Cannon Research Institute on LinkedIn, adding: ''At Sarah…

Oct 22, 2024, 23:50 | Blog

Why clinical trials are essential to delivering patient-centered care - Sarah Cannon Research Institute

Sarah Cannon Research Institute shared a post on LinkedIn: "October is Patient-Centered Care Awareness Month.…

Oct 15, 2024, 00:26 | Blog

Erika Hamilton: Happy to see ASCO's commitment to serving all

Erika Hamilton shared a post by CS Pramesh, Chairman, Tata Memorial Hospital, on X, adding: "Agree, so…

Oct 14, 2024, 18:23 | Blog

Erika Hamilton on WKRN News 2 about common myths about breast cancer

Erika Hamilton shared a post on LinkedIn: "Happy to talk to Blake Eason this morning on…

Oct 12, 2024, 12:57 | Blog

Jenna Fischer's recent breast cancer battle inspires a conversation around early detection and stage 1 triple positive breast cancer treatment - SCRI

SCRI (Sarah Cannon Research Institute) shared a post on LinkedIn: "Important Update: We hope you had…

Oct 11, 2024, 12:32 | Blog

Erika Hamilton: Reflecting on breast cancer research and the importance of clinical trials

Erika Hamilton posted the following on LinkedIn: “Many of us can recall a time in…

Oct 10, 2024, 15:23 | Blog

Erika Hamilton: The Importance of Mammograms - Early Detection Saves Lives

Erika Hamilton shared a post on LinkedIn: "Many of us can recall a time in our…

Oct 6, 2024, 16:50 | Blog

Erika Hamilton: Happy to support Breast Cancer at More than Pink walk

Erika Hamilton shared on LinkedIn: "Happy to support Breast Cancer this morning in Nashville at Susan…

Sep 29, 2024, 09:50 | Blog

Erika Hamilton: ESMO Breast 2025 submission site is now open

Erika Hamilton shared on LinkedIn: "ESMO Breast 2025 submission site is now open. Will be…

Sep 26, 2024, 11:12 | Blog

Vivek Subbiah: Incredibly excited to team up and be featured in the national news on World Cancer Research Day

Vivek Subbiah shared a post on X: "Today is World Cancer Research Day! We are incredibly…

Sep 25, 2024, 12:13 | Insight

World Cancer Research Day 2024: Innovation, Hope, and Progress in the Fight Against Cancer

This year World Cancer Research Day's theme is 'Innovation in Cancer Research Drives Progress Toward…

Sep 24, 2024, 10:36 | Blog

Vivek Subbiah: Live news segment on cutting-edge oncology progress with Erika Hamilton

Vivek Subbiah shared a post on LinkedIn: ''Bright and early! Just recorded a live news…

Sep 23, 2024, 14:23 | Blog

Tatiana Prowell: Ribociclib is now FDA-approved for stage 2 and 3 hormone receptor positive, HER2 negative breast cancer

Erika Hamilton shared on X by Tatiana Prowell, additing: ''Well isn't this a gift for…

Sep 19, 2024, 04:32 | Societies

Best of ESMO24

The ESMO Congress 2024 took place in Barcelona, from September 13 to 17, 2024, at…

Sep 17, 2024, 18:36 | Blog

Erika Hamilton: Masterful discussion of ILD with TDXd by Pat LoRusso

Erika Hamilton shared a post on X: "Masterful discussion of ILD with TDXd by Dr.…

Sep 17, 2024, 16:37 | Blog

Erika Hamilton: KN522 OS data shows 5% overall survival improvement in TNBC with pembrolizumab

Erika Hamilton posted the following on Twitter: “KN522 OS data 5 years after the initial pCR…

Sep 16, 2024, 16:31 | Societies

40 Posts Not To Miss From ESMO24 Day 3

The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at the…

Sep 16, 2024, 15:29 | Societies

Erika Hamilton's Highlights from ESMO24

The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at the…

Sep 15, 2024, 01:23 | Insight

Erika Ruiz-Garcia: Contributing to the creation and development of the ASCO 2025 Annual Meeting Program

Erika Ruiz-Garcia, Chief of the Translational Medicine Laboratory at the National Institute of Cancerology in Mexico…

Sep 14, 2024, 17:15 | Societies

45 Posts not to miss from ESMO24 Day 1

The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at…

Sep 14, 2024, 00:00 | Insight

Komal Jhaveri: The triplet with fulvestrant backbone yielded a mPFS of 35 months in HER2-negative breast cancer

Komal Jhaveri, Patricia and James Cayne Chair for Junior Faculty, Associate Member, Breast Medicine and…

Sep 13, 2024, 08:31 | Blog

Robin Zon: Incredible day at ASCO HQ with Cardinale B. Smith as ASCO25 Education Chair

Robin Zon shared a post on X: ''Incredible day at ASCO HQ with Dr. Cardinale B.…

Sep 13, 2024, 04:43 | Insight

Robin Zon: Appreciate the leadership of Cardinale Smith

Robin Zon shared a post by Cardinale B. Smith, Vice President of Cancer Clinical Services…

Sep 12, 2024, 09:08 | Blog

Erika Hamilton: Fantatsic time working on ASCO25 education program

Erika Hamilton shared on LinkedIn: "Fantatsic time at American Society of Clinical Oncology (ASCO) headquarters…

Sep 10, 2024, 02:20 | Insight

William Pao: The trajectory from laboratory to your neighborhood pharmacy rarely runs in a straight line

Erika Hamilton shared a post by William Pao, on LinkedIn, adding: “So excited to…

Sep 4, 2024, 14:06 | Blog

Erika Hamilton: Happy to join the panel of FDA-ASCO

Erika Hamilton, Breast Executive Committee Director at Sarah Cannon Research Institute, shared a post on…

Aug 25, 2024, 13:09 | Blog

Allison Zibelli and Erika Hamilton discussing data from the DESTINY-Breast06 and A-BRAVE trials

Sidney Kimmel Comprehensive Cancer Center at Jefferson shared a post on LinkedIn: "Dr. Allison Zibelli,…

Aug 7, 2024, 16:50 | Blog

The recipients of the 2024 ESMO Society Awards

The 2024 ESMO Society Awards have been announced on 6th August by ESMO. ESMO recently…